BioHealth Innovation, Inc. (BHI) announced today that John P. Sullivan has joined BHI as a new Entrepreneur-in-Residence (EIR) for the National Institutes of Health (NIH), working with Ethel Rubin, PhD, ventures team head, to provide product, corporate and private investment strategy for NIH portfolio companies.
“We are pleased to have Mr. Sullivan join the team of EIRs serving NIH,” said Richard Bendis, BHI President and CEO. “His expertise in building, operating and acquiring health technology businesses will certainly be an asset as he works to provide the institution with industry insights and commercialization perspectives.”
Established with NIH in 2012, the EIR program is designed to connect NIH-funded start-ups with experienced industry experts who can help them maneuver through multi-disciplinary technical challenges and the business and regulatory environment to deploy new healthcare and biomedical technologies.
“I’m excited for this opportunity to share my entrepreneurial and investment experience with companies that are working to bring cutting-edge health technology to the world,” said Mr. Sullivan. “I hope to connect these companies with the right networks and provide key mentorship during critical early development stages.”
Prior to joining BHI as an EIR, Mr. Sullivan served as Vice President, Strategy, Business Development and Innovation at Cardinal Health. While there he led strategy and business development for pharmaceutical distribution, Cardinal’s largest business unit with more than $100B in revenue. Mr. Sullivan has more than 25 years of business experience in the healthcare sector, including medical devices, healthcare IT, consumer health, pharmacy, supply chain and biotech. He earned a Bachelor of Science in Industrial Engineering, and later a Master of Business Administration, from Stanford University.
“John is an outstanding addition to the ventures team we are building at the NIH’s Office of the Director, Office of Extramural Research,” said Dr. Rubin. “The BHI ventures team prepares NIH portfolio companies for private investment with product, business development and funding strategy support. John’s expertise and network are an invaluable resource to enhance our efforts.”
More information on the EIR program can be found at http://www.biohealthinnovation.org/programs/entrepreneur-in-residence-program.
About BioHealth Innovation, Inc.
BioHealth Innovation, Inc., is a BioHealth Capital Region (BHCR) regional innovation intermediary that supports the transformation of research projects into new business opportunities in partnership with the region's rich assets, institutions, and entrepreneurial community. BHI achieves this goal by being a catalytic partner in the economic development ecosystem. In the past seven years, BHI has successfully supported the transformation of many small entrepreneurial research teams into funded biohealth companies. Genetic Engineering and Biotechnology News recently ranked the BHCR as the “Number 4” BioHealth cluster in the United States. Learn more at www.BioHealthinnovation.org.